| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -61,180 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR/A | Adage Capital Partners Gp Llc | Institution | 2,894,500 | No Change | 0 | 0 % | $6,483,680 | $6,338,955 | $-144,725 | -2.23 % | $0 | | | | | | News Article | History of Adage Capital Partners Gp Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | | Sold All | -12,882 | -100 % | | | | -2.23 % | $644 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | | Sold All | -14,461 | -100 % | | | | -3.52 % | $1,157 | | | | | | News Article | History of Amvescap Plc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 2,000 | No Change | 0 | 0 % | $4,540 | $4,380 | $-160 | -3.52 % | $0 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bridgeway Capital Management Inc | Institution | 18,558 | New Holding | 18,558 | 100 % | $41,384 | $40,642 | $-742 | -1.79 % | $-742 | | | | | | News Article | History of Bridgeway Capital Management Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Dafna Capital Management Llc | Institution | | Sold All | -585,300 | -100 % | | | | -1.79 % | $23,412 | | | | | | News Article | History of Dafna Capital Management Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Driehaus Capital Management Llc | Institution | 631,732 | New Holding | 631,732 | 100 % | $1,408,762 | $1,383,493 | $-25,269 | -1.79 % | $-25,269 | | | | | | News Article | History of Driehaus Capital Management Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 1,379,650 | No Change | 0 | 0 % | $3,076,620 | $3,021,434 | $-55,186 | -1.79 % | $0 | | | | | | News Article | History of Fmr Corp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Jay Jeffrey R | Institution | 3,132,476 | Added More | 132,476 | 4.41 % | $6,985,421 | $6,860,122 | $-125,299 | -1.79 % | $-5,299 | | | | | | News Article | History of Jay Jeffrey R Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 442,112 | Sold Some | -53,001 | -10.70 % | $985,910 | $968,225 | $-17,684 | -1.79 % | $2,120 | | | | | | News Article | History of Millennium Management Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 94,000 | Added More | 72,953 | 346.61 % | $209,620 | $205,860 | $-3,760 | -1.79 % | $-2,918 | | | | | | News Article | History of Morgan Stanley Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 110,095 | Added More | 10,497 | 10.53 % | $245,512 | $241,108 | $-4,404 | -1.79 % | $-420 | | | | | | News Article | History of Northern Trust Corp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | | Sold All | -90,820 | -100 % | | | | -1.79 % | $3,633 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | 310,100 | Sold Some | -1,485,900 | -82.73 % | $691,523 | $679,119 | $-12,404 | -1.79 % | $59,436 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Principled Asset Administration Llc | Institution | 987,100 | Sold Some | -260,600 | -20.88 % | $2,201,233 | $2,161,749 | $-39,484 | -1.79 % | $10,424 | | | | | | News Article | History of Principled Asset Administration Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Qvt Financial Lp | Institution | 333,136 | Added More | 46,700 | 16.30 % | $742,893 | $729,568 | $-13,325 | -1.79 % | $-1,868 | | | | | | News Article | History of Qvt Financial Lp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 856,473 | Added More | 842,323 | 5952.81 % | $1,909,935 | $1,875,676 | $-34,259 | -1.79 % | $-33,693 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | | Sold All | -14,500 | -100 % | | | | -1.79 % | $580 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 3,442,312 | Added More | 360,100 | 11.68 % | $7,676,356 | $7,538,663 | $-137,692 | -1.79 % | $-14,404 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 10,000 | New Holding | 10,000 | 100 % | $21,900 | $21,900 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 146,816 | New Holding | 146,816 | 100 % | $321,527 | $321,527 | $0 | 0.00 % | $0 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 112,560 | Added More | 48,830 | 76.62 % | $246,506 | $246,506 | $0 | 0.00 % | $0 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 60,268 | Sold Some | -20,659 | -25.52 % | $131,987 | $131,987 | $0 | 0.00 % | $0 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jennison Associates Llc | Institution | 2,961,800 | Sold Some | -643,600 | -17.85 % | $6,486,342 | $6,486,342 | $0 | 0.00 % | $0 | | | | | | News Article | History of Jennison Associates Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 16,040 | Sold Some | -89,131 | -84.74 % | $35,128 | $35,128 | $0 | 0.00 % | $0 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | | Sold All | -2,250 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 209,900 | Sold Some | -880,700 | -80.75 % | $459,681 | $459,681 | $0 | 0.00 % | $0 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Spark Lp | Institution | | Sold All | -28,000 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Spark Lp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Tokum Capital Management Lp | Institution | | Sold All | -117,393 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Tokum Capital Management Lp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 699,610 | Added More | 208,364 | 42.41 % | $1,532,146 | $1,532,146 | $0 | 0.00 % | $0 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 143,145 | Added More | 360 | 0.25 % | $316,350 | $313,488 | $-2,863 | -0.90 % | $-7 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bbt Capital Management Inc | Institution | 550,000 | Sold Some | -50,000 | -8.33 % | $1,215,500 | $1,204,500 | $-11,000 | -0.90 % | $1,000 | | | | | | News Article | History of Bbt Capital Management Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 468,500 | No Change | 0 | 0 % | $1,035,385 | $1,026,015 | $-9,370 | -0.90 % | $0 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Ubs Oconnor Llc | Institution | | Sold All | -19,300 | -100 % | | | | -0.90 % | $386 | | | | | | News Article | History of Ubs Oconnor Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Baker Bros Advisors Llc | Institution | 134,792 | No Change | 0 | 0 % | $296,542 | $295,194 | $-1,348 | -0.45 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 13,321 | New Holding | 13,321 | 100 % | $29,306 | $29,173 | $-133 | -0.45 % | $-133 | | | | | | News Article | History of Citigroup Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 273,626 | Added More | 63,226 | 30.05 % | $601,977 | $599,241 | $-2,736 | -0.45 % | $-632 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Royce And Associates Llc | Institution | 70,400 | Sold Some | -40,000 | -36.23 % | $154,880 | $154,176 | $-704 | -0.45 % | $400 | | | | | | News Article | History of Royce And Associates Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 100,770 | Sold Some | -189,480 | -65.28 % | $221,694 | $220,686 | $-1,008 | -0.45 % | $1,895 | | | | | | News Article | History of Ubs Ag Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 781,400 | Added More | 16,400 | 2.14 % | $1,640,940 | $1,711,266 | $70,326 | 4.28 % | $1,476 | | | | | | News Article | History of Federated Investors Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Goldman Jay G | Institution | 85,000 | Sold Some | -85,000 | -50.00 % | $178,500 | $186,150 | $7,650 | 4.28 % | $-7,650 | | | | | | News Article | History of Goldman Jay G Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 93,644 | Sold Some | -51,900 | -35.65 % | $196,652 | $205,080 | $8,428 | 4.28 % | $-4,671 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Dowling And Yahnke Inc | Institution | 62,034 | Added More | 28,034 | 82.45 % | $111,041 | $135,854 | $24,814 | 22.34 % | $11,214 | | | | | | News Article | History of Dowling And Yahnke Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 515,918 | No Change | 0 | 0 % | $923,493 | $1,129,860 | $206,367 | 22.34 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 229,749 | Added More | 146,213 | 175.02 % | $448,011 | $503,150 | $55,140 | 12.30 % | $35,091 | | | | | | News Article | History of Oxford Asset Management Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 1,441 | No Compare | | | $2,810 | $3,156 | $346 | 12.30 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Jennison Sector Funds Inc - Jennison Health Sciences Fund | Health/Biotech | 2,407,700 | New Holding | 2,407,700 | 100 % | $4,695,015 | $5,272,863 | $577,848 | 12.30 % | $577,848 | | | | | | News Article | History of Jennison Sector Funds Inc - Jennison Health Sciences Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 304,223 | Sold Some | -13,200 | -4.15 % | $626,699 | $666,248 | $39,549 | 6.31 % | $-1,716 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 8,800 | Added More | 800 | 10.00 % | $19,800 | $19,272 | $-528 | -2.66 % | $-48 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 60,987 | No Change | 0 | 0 % | $142,710 | $133,562 | $-9,148 | -6.41 % | $0 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-15 | 2009-08-31 | N-Q | Allied Asset Advisors Funds - Allied Asset Advisor Funds | Specialty & Misc | 51,000 | New Holding | 51,000 | 100 % | $113,220 | $111,690 | $-1,530 | -1.35 % | $-1,530 | | | | | | News Article | History of Allied Asset Advisors Funds - Allied Asset Advisor Funds Ownership Of Anadys Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 46,710 | Sold Some | -12,296 | -20.83 % | $103,229 | $102,295 | $-934 | -0.90 % | $246 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 23,741 | No Change | 0 | 0 % | $63,863 | $51,993 | $-11,871 | -18.58 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 9,043 | No Change | 0 | 0 % | $24,326 | $19,804 | $-4,522 | -18.58 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 800 | No Change | 0 | 0 % | $2,152 | $1,752 | $-400 | -18.58 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Trust Co - International Value Series | Multi-Cap Value | | Sold All | -201 | -100 % | | | | -18.58 % | $101 | | | | | | News Article | History of Dfa Investment Trust Co - International Value Series Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -1,680 | -100 % | | | | -17.66 % | $790 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -3,100 | -100 % | | | | -17.66 % | $1,457 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Nationwide Mutual Funds - Nationwide Large Cap Value Fund | Large-Cap Value | | Sold All | -1,300 | -100 % | | | | -15.11 % | $507 | | | | | | News Article | History of Nationwide Mutual Funds - Nationwide Large Cap Value Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 142,785 | Added More | 22,155 | 18.36 % | $371,241 | $312,699 | $-58,542 | -15.76 % | $-9,084 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Japan Fund | Japanese | | Sold All | -6 | -100 % | | | | -17.04 % | $3 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Japan Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Small Cap Core Fund | Small-Cap Core | 87 | Added More | 56 | 180.64 % | $230 | $191 | $-39 | -17.04 % | $-25 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Small Cap Core Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Core Bond Fund | Multi-Cap Core | 87 | New Holding | 87 | 100 % | $230 | $191 | $-39 | -17.04 % | $-39 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Core Bond Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 2,930 | Added More | 1,130 | 62.77 % | $7,735 | $6,417 | $-1,319 | -17.04 % | $-509 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 57,338 | New Holding | 57,338 | 100 % | $151,372 | $125,570 | $-25,802 | -17.04 % | $-25,802 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 2,480 | Added More | 1,480 | 148.00 % | | $5,431 | | - % | | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR | Algert Coldiron Investors Llc | Institution | | Sold All | -2,690 | -100 % | | | | -20.07 % | $1,480 | | | | | | News Article | History of Algert Coldiron Investors Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 14,461 | New Holding | 14,461 | 100 % | $39,623 | $31,670 | $-7,954 | -20.07 % | $-7,954 | | | | | | News Article | History of Amvescap Plc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 1,379,650 | Sold Some | -2,367,523 | -63.18 % | $3,780,241 | $3,021,434 | $-758,808 | -20.07 % | $1,302,138 | | | | | | News Article | History of Fmr Corp Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 50,765 | Added More | 12,012 | 30.99 % | $114,221 | $111,175 | $-3,046 | -2.66 % | $-721 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 2,000 | No Change | 0 | 0 % | $4,500 | $4,380 | $-120 | -2.66 % | $0 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 246,589 | New Holding | 246,589 | 100 % | $559,757 | $540,030 | $-19,727 | -3.52 % | $-19,727 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 144,240 | New Holding | 144,240 | 100 % | $327,425 | $315,886 | $-11,539 | -3.52 % | $-11,539 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 21,879 | No Change | 0 | 0 % | $49,665 | $47,915 | $-1,750 | -3.52 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 14,400 | New Holding | 14,400 | 100 % | $32,688 | $31,536 | $-1,152 | -3.52 % | $-1,152 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Anadys Pharmaceuticals Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |
RSS feed for ANDS